Engineering stem cells for treatment of osteochondral defects

Skeletal Radiology

Volumn 41, Issue 1, 2012, Pages 1-4

  Nejadnik, Hossein ^a   Daldrup Link, Heike E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR;

AMNION FLUID; ASPIRATION BIOPSY; BONE GRAFT; CARTILAGE CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL REGENERATION; CONTROLLED STUDY; DISEASE COURSE; EMBRYONIC STEM CELL; FIBROCARTILAGE; HUMAN; JOINT MOBILITY; MICROFRACTURE; MINIMALLY INVASIVE SURGERY; OSTEOCHONDRITIS DISSECANS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; STEM CELL; TISSUE TRANSPLANTATION; UMBILICAL CORD BLOOD;

CARTILAGE, ARTICULAR; CELL ENGINEERING; CELL TRACKING; HUMANS; OSTEOCHONDRITIS; STEM CELL TRANSPLANTATION;

EID: 84856283489     PISSN: 03642348     EISSN: 14322161     Source Type: Journal    
DOI: 10.1007/s00256-011-1272-6     Document Type: Review

References (12)

1. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331 (14):889-95. (Pubitemid 24299869)
2. Nejadnik H, Hui JH, Feng Choong EP, Tai BC, Lee EH. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010;38(6):1110-6.
3. Toh WS, Lee EH, Guo XM, Chan JK, Yeow CH, Choo AB, et al. Cartilage repair using hyaluronan hydrogel-encapsulated human embryonic stem cell-derived chondrogenic cells. Biomaterials. 2010;31(27):6968-80.
4. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. 2005;26(27):5474-91. (Pubitemid 40592136)
5. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials. 2006;27(18):3413-31.
6. Uebersax L, Hagenmuller H, Hofmann S, Gruenblatt E, Muller R, Vunjak-Novakovic G, et al. Effect of scaffold design on bone morphology in vitro. Tissue Eng. 2006;12(12):3417-29. (Pubitemid 46037165)
7. Luong-Van E, Grondahl L, Song S, Nurcombe V, Cool S. The in vivo assessment of a novel scaffold containing heparan sulfate for tissue engineering with human mesenchymal stem cells. J Mol Histol. 2007;38(5):459-68. (Pubitemid 350056777)
8. Henning TD, Gawande R, Khurana A, Tavri L, Mandrussow D, Golovko D, et al. Magnetic resonance imaging of ferumoxide labeled mesenchymal stem cells in cartilage defects: in vitro and in vivo investigations. Mol Imaging. 2011 (in press)
9. Nedopil A, Klenk C, Kim C, Liu S, Wendland M, Golovko D, et al. MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-associated stem cell implants for treatment of osteoarthritis. Invest Radiol. 2010;45(10):634-40.
10. Henning TD, Wendland MF, Golovko D, Sutton EJ, Sennino B, Malek F, et al. Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells. Magn Reson Med. 2009;62(2):325-32.
11. Castaneda R, Khurana A, Khan R, Daldrup-Link HE. Labeling stem cells with ferumoxytol, an FDA-approved iron oxide nanoparticle. J Vis Exp. 2011 (in press)
12. Khurana A, Nejadnik H, Gawande R, Lee S, Castaneda R, Derugin N, et al. Intravenous ferumoxytol allows non-invasive MR monitoring of macrophage migration into stem cell transplants. World Molecular Imaging Congress, San Diego, CA, Sep 2011